Contract No: CFTD/2010/XXX
TITLE
(Acronym)
Institute Name A
&
Institute Name B
TD Collaborative Annex
Rev-06
1/19
Annex 1:
Payment
No.
Payment Schedule
Amount in
€
% of total
1
2
30%
30%
3
30%
4
10%
1+2+3+4
Ref: CFTD/10/XXX A
Payment Date
Payment Date
01/mm/yyyy
On signing of contract
On receipt of satisfactory
interim PI Report after 1 year of
project start date
On receipt of satisfactory
interim PI Report after 2 years
of project start date
On receipt of satisfactory final
PI Report
100%
Ref: CFTD/10/XXX B
Payment
No.
Amount in
€
% of total
1
2
30%
30%
3
30%
4
10%
1+2+3+4
Payment Date
Payment Date
01/mm/yyyy
On signing of contract
On receipt of satisfactory
interim PI Report after 1 year of
project start date
On receipt of satisfactory
interim PI Report after 2 years
of project start date
On receipt of satisfactory final
PI Report
100%
Note 1: All payments are subject to the satisfactory achievement of milestones and deliverables
as set out in Annex 2, and to the submission of satisfactory and timely yearly reports. Final
payment is subject to receipt by Enterprise Ireland of the project’s Final Report.
Note 2: Project expenditure must reach at least 70% of interim payments made before further
claims can be submitted.
Note 3: Enterprise Ireland reserves the right to alter the payment schedule over the course of this
contract.
Note 4: For the purpose of this agreement, all required deliverables as set out in Annex 2 should
be submitted to Enterprise Ireland by electronic format (e.g. as a Word document). Paper
documents are not required.
The following Notes apply to Annexes for the Informatics/ICT contracts
Note 5: (i) Disclosure of Foreground IP through “open source” publication, without the prior
written consent of Enterprise Ireland to such publication, shall constitute a breach of Clause 8.1 of
this Agreement.
(ii) Without prejudice to the generality of Clause 9 of this Agreement the Designated
Institution shall not use “open-source” software as part of the Project without first ensuring that
such use shall not affect its right to full and unfettered ownership of all Foreground IP.
Note 6: Where a Project deliverable is a tangible object (such as, for example, a circuit board, a
printout of a software program or a physical substance) the Designated Institution shall not
forward the object itself to Enterprise Ireland, but shall submit to Enterprise Ireland a document
containing a description of the object, and such further documents containing such clarifying
details as Enterprise Ireland may require. In addition the Designated Institution shall retain the
object for inspection by Enterprise Ireland’s assessors for the period of this Agreement.
TD Collaborative Annex
Rev-06
2/19
The following notes apply to financial claims and ledgers forwarded to Enterprise Ireland.
Financial Claims:
When submitting financial claims with respect to this project, please note as a guide that the
following costs are ineligible:
This list is non-exhaustive.




























Any interests, or return on capital employed
Provisions for possible future losses or charges
Interest owed
Provisions for doubtful debts
Resources made available to a Grantee free of charge
Unnecessary or ill-considered expenses
Marketing, sales and distribution costs for products and services
Entertainment and hospitality expenses except such reasonable expenses accepted as wholly and
exclusively necessary for carrying out the work under the Standard Grand Agreement
Fees and penalties (including prompt payment interest)
Recruitment costs, work permits/ visas, accommodation etc
Redundancy costs
Relocation costs
Interview expenses
Subsistence payments to visiting personnel who are not on the payroll of the institute
Protection of Intellectual property rights (separate support)
Cost of courses (unless the course relates directly to the project)
Membership fees (unless the membership relates directly to the project)
Subscription costs (unless the subscription relates directly to the project)
General stationary
Office Equipment
General phone charges
Provision of work space
Books (maximum of €1,500)
Any items which are detailed as Miscellaneous or General
Advertising
Consultancy (EI have set a limit of €900/day inclusive of all travel and expenses)
Petty Cash (Limit of €1,500 per project)
Travel & Expenses (unless destination, duration and activity is appropriate)
Financial Ledgers:
The financial ledgers for this project must contain the following:





Clear description
Supplier name
Category of expenditure
Amount
Invoice number
All travel or expense claims must include the persons name, destination and reason for travelling.
A pay claim must in all cases include the person’s name.
TD Collaborative Annex
Rev-06
3/19
Annex 2:
This must be completed for each institute
Institute Name:
Administrative Details
Project Title
Acronym
Sector
Designated Institution
Department
Address
Principal Investigator
Principal Investigator Tel
Principal Investigator email
Collaborating Institution
Start Date
Completion Date
Duration (months)
Commercialisation Specialist
TD Collaborative Annex
Rev-06
4/19
Annex 2:
Individual Cost Structure
Ref: CFTD/10/XXX X
Include fees for postgraduates, annual salary increments, employers PRSI contribution
and pension costs (max 15%). Refer to the IUA salary scale for employee’s gross
salary.
Qualification
% Time
Candidate & Position
currently held
on
Project
COST
€
Salary
PRSI (10.75%) or fees
Pension (≤15%)
Salary
PRSI (10.75%) or fees
Pension (≤15%)
Salary
PRSI (10.75%) or fees
Pension (≤15%)
Total
Justification (e.g. Postdoc 1 will carry out the work on XYZ etc.):
Non-pay: Materials
All items listed should be fully detailed.
Include what materials are needed and estimates of quantities and costings.
€
Total
Justification:
Non-pay: Travel (Domestic)
Please list person travelling and reason for travel.
€
Total
Non-pay: Travel (Overseas)
Please list person travelling and reason for travel.
€
Total
Justification for all travel (e.g. trade show X or conference Y or company visits Z will
provide valuable information for work packages g, h, and k etc):
TD Collaborative Annex
Rev-06
5/19
Non-pay: Subcontract
Detail any costs relating to sub-contracting, consultancy etc.
Consultancy costs – consultant’s work plan and deliverables require EI approval prior
to engagement.
€
Total
Justification:
Non-pay: Other
€
Total
Justification:
Capital (Equipment)
All items listed should be fully detailed.
Please include commercial quotation on items over €5000.
€
Total
Justification (e.g. the ABC analyser will be used for tasks 3, 5, and 7 etc.):
TOTAL COST FOR INSTITUTE X
TD Collaborative Annex
€
Rev-06
6/19
Project Description for: Institute Name
WP #
Title:
Start Date
Description
Month
Milestone(s)
M#.1.
M#.2.
Deliverable(s)
D#.1.
D#.2.
WP #
Title:
Start Date
Description
Month
Milestone(s)
M#.1.
M#.2.
Deliverable(s)
D#.1.
D#.2.
WP #
Title:
Start Date
Description
Month
Finish Date
CFTD/10/XXX X
Month
Month
Finish Date
Month
Month
Finish Date
Month
Month
Milestone(s)
M#.1.
M#.2.
Deliverable(s)
D#.1.
D#.2.
TD Collaborative Annex
Rev-06
7/19
WP #
Title:
Start Date
Description
Month
Milestone(s)
M#.1.
M#.2.
Deliverable(s)
D#.1.
D#.2.
WP #
Title:
Start Date
Description
Month
Milestone(s)
M#.1.
M#.2.
Deliverable(s)
D#.1.
D#.2.
WP #
Title:
Start Date
Description
Month
Milestone(s)
M#.1.
M#.2.
Deliverable(s)
D#.1.
D#.2.
Finish Date
Month
Month
Finish Date
Month
Month
Finish Date
Month
Month
TD Collaborative Annex
Rev-06
8/19
Summary of deliverables
Dx.x
Deliverable
D1.1
Statement of Product, Uniqueness, Market
benefit
List of potential licensees, mentor, industry
groups
Commercial intent of research group
Overview of industry sector
Focussed market leads
Elevator Speech
Business Plan / Marketing Strategy
Presentation Pack
Demo of the technology, where appropriate
D1.2
D1.3
D2.1
D2.2
D3.1
D3.2
D3.3
D3.4
D4.1
D4.2
Month
Due
Institute
initials
Submit
deliverable
to EI (Y/N)
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
Reviews and reporting requirements
Nature of review/report
Initial (Kick-off) meeting
6 month meeting
Interim report + meeting
6 month meeting
Interim report + meeting
6 month meeting
Final report + meeting
Notification of new Intellectual Property
to Technology Transfer Office
Date of review /report
Updated as required
Final Deliverable
What the project aims to achieve (brief but specific)
TD Collaborative Annex
Rev-06
9/19
Include a Gantt chart also on the last page.
TD Collaborative Annex
Rev-06
10/19
Annex 3:
Administrative Details
Project Title
Acronym
Sector
Designated Institution
Department
Address
Principal Investigator
Principal Investigator Tel
Principal Investigator email
Collaborating Institution
Start Date
Completion Date
Duration (months)
TD Collaborative Annex
Rev-06
11/19
Annex 3:
Consolidated Financial details (A&B)
Pay costs
Category
Salary
Cost in €
Employer
PRSI
10.75%
Pension
(rate) %
(Max
15%)
Total in
€
No.
Person
months
P.I.
Senior
Researcher
Researcher
Post
Graduates (2)
Other
Sub-total
Pay
Non-pay Costs
Cost in €
Category
Specific Details if
applicable
Consumables/materials
Subcontract/consultancy
Travel (domestic)
Travel (overseas)
Other non-pay
Sub-total Non-Pay costs
Capital costs
Capital item
Cost in €
Sub-total capital
Cost Summary
Category
€
Pay costs
Non-pay costs
Capital costs
Total Project costs (A&B)
TD Collaborative Annex
Rev-06
12/19
Confidential not to be released
Project Description:
Objective:
Project Summary:
TD Collaborative Annex
Rev-06
13/19
Project Plan for both Institutes
Name of Institute Responsible:
WP 1
Commercialisation Stage 1:Product & Market Awareness
Start Date
Description
Month 1
Finish Date
Month 12
Background.
The Researcher will be expected to demonstrate how the technology will compare
to others on the market.
The researcher needs to look at why someone would buy their technology. What
benefit does it bring to the purchaser? What other options does a purchaser have,
i.e. other technologies, performance criteria etc. What products/companies offer
something similar (or an alternative) to a purchaser?
Consultancy
The PI should avail of consultancy , sourced with assistance of the Institute
Name Research Office and Technology Area, aimed at commercialising the work
Month
M1.1 Identification of product, market and initial relevant segments
D1.1: Statement of Product, Uniqueness, Market benefit
D1.2: List of potential licensees, mentors, industry groups etc.
D1.3: Commercial intent of research group (start-up, licence, etc.)
-
Milestones
Deliverables
TD Collaborative Annex
Rev-06
14/19
Name of Institute Responsible:
WP 2
Commercialisation Stage 2: Industry Analysis
Start Date
Description
Month: 13
Finish Date
Month 18
Background.
At stage 2, the researcher has built up a profile of how their product/technology
compares to the existing products/technologies. In this phase, it is important to
understand how the industry is structured and where will the research technology
potentially fit. Questions which are required to be asked in this phase are – where
does my technology fit – what industries, who are the users, who buys the
technology, is it integrated within another product, is it stand alone? Which market
segments are relevant?
Product Description Example
The research team should draw up a document which addresses D1.1, and D2.1.
The document is intended for posting in the public arena (that will not disclose IP
sensitive information), web sites, exhibitions, posting to potential interested
parties. The exact format may be prescribed by the Institute or take the form of a
Technology Capsule as in D2.3.
Month
Milestones
Deliverables
M2.1: Desktop market survey of end-users, overall market size /
value of market, expected market share for proposed technology
M2.2: Attendance at relevant industry trade show after IP review
with Institute Name Research Office/Technology Area to
prevent any IP disclosures
M2.3: Attend networking events, meetings with mentors, EI HPSU
team.
M2.4: Data from technical WP’s to show product has
expected/desired effect.
D2.1: Overview of the industry sector - including market size for
the technology, where the product is positioned, e.g. relative to
competitors, for targeting relevant segments of the market.
D2.2: Focused Market leads, - CEO, VC, licensees (from WP1:D1.2
above).
TD Collaborative Annex
Rev-06
-
15/19
Name of Institute Responsible:
WP 3
Commercialisation WP3:Market Engagement
Start Date
Description
Month 1
Finish Date
Month 36
Background
Active engagement with industry players – industrialists, investors, “showcase
events”.
If the preferred commercialisation route is licensing, the PI and EI
Commercialisation Specialist, in consultation with the Institute Name Research
Office, will develop a marketing strategy for the licensees identified in D2.2 (e.g.
using the technology capsule and/or showcasing events). A 5 minute presentation
or “Elevator Speech” outlining the commercial opportunity will be prepared.
Professional legal advice will be sought to identify appropriate licensing deal
structures for this technology.These interactions will only take place after
appropriate IP protection (following engagement of patenting expertise) is in place
and following advice from appropriate experts in Enterprise Ireland.
If the company formation route is being investigated, then development of a
business plan outlining route to market will take place with help/advice from
internal experts (in EI and Institute Name) and external consultants if required.
Logos below should be shown on all presentations, brochures, web pages
etc. to acknowledge funding source
See link below and click on download corporate mark for the EI Logo
http://www.enterprise-ireland.com/AboutUs/logo/ei_logo.htm
Ireland’s EU Structural Funds logo and the EU flag are available to download form
the Managing Authorities websites: www.bmwassembly.ie, www.seregassembly.ie.
Month
Milestones
Deliverable(s)
M3.1: Patent application filed
M3.2: Preparation of “Elevator Pitch” and presentations with
Institute Name Research Office & EI Commercialisation Specialist
M3.3: Identification of key contacts / names of potential investors
/industrial partners & potential licensees
M3.4: Meetings and interaction under NDA with people identified
from M3.3
M3.5: Business plan identifying route to market strategy (start-up,
licensing, joint venture, etc).
D3.1: Delivery of “Elevator Speech”
D3.2 :Business Plans and/or marketing strategy as in M3.5
D3.3 A presentation pack, where the technology can be presented
to interested parties.
D3.4 A demonstration of the technology, where appropriate.
TD Collaborative Annex
Rev-06
-
16/19
Name of Institute Responsible:
WP 4
Title:
Start Date
Description
Month
Milestone(s)
M4.1.
M4.2.
Deliverable(s)
D4.1.
D4.2.
Finish Date
Month
Month
Name of Institute Responsible:
WP 5
Title:
Start Date
Description
Month
Milestone(s)
M5.1.
M5.2.
Deliverable(s)
D5.1.
D5.2.
Finish Date
Month
Month
Name of Institute Responsible:
WP 6
Title:
Start Date
Description
Month
Milestone(s)
M6.1.
M6.2.
Deliverable(s)
D6.1.
D6.2.
Finish Date
Month
Month
TD Collaborative Annex
Rev-06
17/19
Summary of deliverables
Dx.x
Deliverable
D1.1
Statement of Product, Uniqueness, Market
benefit
List of potential licensees, mentor, industry
groups
Commercial intent of research group
Overview of industry sector
Focussed market leads
Elevator Speech
Business Plan / Marketing Strategy
Presentation Pack
Demo of the technology, where appropriate
D1.2
D1.3
D2.1
D2.2
D3.1
D3.2
D3.3
D3.4
D4.1
D4.2
Month
Due
Institute
initials
Submit
deliverable
to EI (Y/N)
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
Reviews and reporting requirements
Nature of review/report
Initial (Kick-off) meeting
6 month meeting
Interim report + meeting
6 month meeting
Interim report + meeting
6 month meeting
Final report + meeting
Notification of new Intellectual Property
to Technology Transfer Office
Date of review /report
Updated as required
Final Deliverable
What the project aims to achieve (brief but specific)
TD Collaborative Annex
Rev-06
18/19
Include a Gantt chart also on the last page.
TD Collaborative Annex
Rev-06
19/19